Skip to Content

Lofibra 134 mg Gate 323 (Lofibra 134 mg)

Generic Name: fenofibrate

Pill imprint Lofibra 134 mg Gate 323 has been identified as Lofibra 134 mg.

Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lofibra 134 mg Lofibra 134 mg Gate 323
Lofibra 134 mg Lofibra 134 mg Gate 323
Discount Card Promo
Lofibra
Generic Name:
fenofibrate
Imprint:
Lofibra 134 mg Gate 323
Strength:
134 mg
Color:
Blue
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Gate Pharmaceuticals
National Drug Code (NDC):
57844-0323
Inactive Ingredients:
croscarmellose sodium
crospovidone
lactose monohydrate
magnesium stearate
povidone k25
corn starch
sodium lauryl sulfate
D&C Red No. 28
FD&C Blue No. 1
titanium dioxide
gelatin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide